MyoKardia Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Citi cuts investment banking analyst program to two years - Bloomberg
- Alaska LNG shipping savings justifies billions in investment, developer says
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Nasdaq notches record high close as investors focus on earnings
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
MyoKardia (MYOK) IPO Opens 10% Higher
October 29, 2015 10:48 AM EDTToday's IPO for MyoKardia (NASDAQ: MYOK) opened for trading at $11.08 after pricing 5,437,500 shares of common stock at a public offering price of $10.00 per share.
Credit Suisse Securities (USA) LLC and Cowen and Company, LLC are acting as lead book-running managers. Wells Fargo Securities is acting as book-running manager. Wedbush PacGrow is acting as co-manager.
MyoKardia is a clinical stage... More



